Latest News
GP Bullhound has acted as exclusive financial advisor to Jellyfish on the strategic investment by Fimalac Group which will also see Tradelab (part of Fimalac Group) integrated into Jellyfish. The deal will put the value of the new enlarged Jellyfish at circa GBP500 million.
Founded in the UK in 2005, Jellyfish has grown at 45 per cent per annum over the last eight years and today employs 780 staff in 23 offices across the world. It has established itself a one of a select few globally managed Google Marketing Partners and is a global digital partner to leading brands including
Bruin Sports Capital (Bruin), a privately held global investing, operating and holding company has entered into a wide-ranging, long-term strategic partnership with private equity firms CVC Capital Partners (CVC) and The Jordan Company (TJC), to build best-in-class sports and entertainment companies.
The deal gives Bruin access to billions in capital, plus a global network of resources from the partners beginning with an initial combined investment for USD600 million from CVC Fund VII and TJC’s Resolute Fund IV.
“We are extremely proud to have the partnership and support of CVC Capital Partners and The Jordan Company, not only for what
UBS Asset Management’s (UBS-AM) Real Estate & Private Markets (REPM) Infrastructure business has completed the acquisition of a 49.9 perf cent stake in Phoenix Wind Repower, a portfolio of three wind farms located in Texas, USA, on behalf of its infrastructure equity strategy.
The stake has been acquired from a fund managed by Ares Management Corporation’s Infrastructure and Power strategy, which develops and owns power assets in the USA, and which retains a 50.1 per cent interest in the asset.
The three wind farms, initially commissioned between 2008 and 2012 with Clipper turbines, are currently being repowered by Vestas
An affiliate of private equity investment firm HIG Capital (HIG) has completed the acquisition of BioVectra, a contract development and manufacturing organisation (CDMO) of active pharmaceutical ingredients and intermediates.
Founded in 1970, BioVectra’s core competencies include microbial fermentation, complex chemistry, high potency, and biologics. They impact the lives of patients by producing products that are used to treat cancer, kidney disease, cardiovascular disease, multiple sclerosis, and many other complex diseases. The Company is strategically located in Canada with over 110,000 sq ft of manufacturing space uniquely designed to support its biopharmaceutical clients from the early stages of clinical development to
LeapFrog Investments today has Julia Gillard, Simon Israel and Jaime A Zobel de Ayala to its Global Leadership Council. Members of the Council provide strategic insight and global networks to support LeapFrog’s goal to reach 1 billion people with essential services by 2030.
LeapFrog’s companies currently reach 188 million people with healthcare or financial tools. The firm’s new and record-breaking USD743 million impact investing fund presents the strategic opportunity to expand this impact while generating strong returns for investors – guided by the Council.
Gillard is the former Prime Minister of Australia, who successfully oversaw the world’s twelfth largest
CVC-backed Omada, a provider of Identity Governance and Administration (IGA) software and cloud delivered IGA services, has appointed Michael Garrett as CEO.
IGA services improve the compliance and IT security, manage secure access across all corporate systems, ensure employee access is compliant with access policies and help automate IT processes for better efficiency.
Garrett has experience in software and services, most recently working as CEO for Workshare, a UK-based provider of secure enterprise file sharing and collaboration applications.
Garrett will bring his global software experience to the existing leadership team enabling the acceleration of Omada’s growth.
He
BGF has exited its investment in Thames Technology, one of the UK’s largest manufacturers and designers of payment, loyalty and gift cards.
The business has been acquired by Paragon ID, the Paris-listed provider of identification and traceability solutions.
BGF first invested in Essex-based Thames Technology in 2013, with GBP3.1 million to support the acquisition of new manufacturing equipment. Since then, the business has increased production capacity, improved its service offering, and strengthened its reputation in the UK and internationally with customers across the retail and financial services sectors.
BGF investor and Head of Manufacturing Mark Bryant, who will
Pivot Power (Pivot), a privately-owned developer of transmission-connected battery storage and electric vehicle (EV) charging networks, has been acquired by EDF Renewables UK from funds managed by Downing LLP.
Downing has partnered with Pivot since its inception in 2017, providing investment and support to secure 45 sites across the UK as part of the stage of a world-first EV charging and grid connected battery network. The funding and support have allowed Pivot to expand from two employees to a team of 15.
As well as providing critical infrastructure for EV charging, Pivot’s battery development portfolio represents a huge increase
Avista-backed Cosette Pharmaceuticals acquires of G&W Laboratories’ finished dosage manufacturing plant.
Cosette Pharmaceuticals, a generic pharmaceutical company focused on extended topical and suppository products and portfolio company of Avista, has purchased G&W Laboratories’ finished dosage manufacturing plant located in Lincolnton, NC.
“The purchase of the Lincolnton plant expands Cosette’s capabilities into new dosage forms while simultaneously allowing us to enter a new business vertical that complements our overall growth strategy,” says Walt Kaczmarek, President and Chief Executive Officer of Cosette. “The Lincolnton facility has an excellent track record of producing liquid pharmaceuticals along with other differentiated dosage forms, and
Arcmont Asset Management (Arcmont) has launched as an independent private debt business following the completion of its separation from BlueBay Asset Management (BlueBay).
Arcmont currently manages institutional assets of over EUR13 billion and is focused on delivering flexible capital solutions to businesses across Europe. The company is employee owned and managed and is backed by a minority investment from Dyal Capital Partners (Dyal), a specialist in investments in alternative asset managers globally.
Arcmont also announces the launch of its newly-formed Capital Solutions strategy with the hiring from January 2020 of two senior investment professionals, David Brooks and Alice Cavalier,
Special Reports
Featured
Events
12 November, 2026 – 8:00 am
12 November, 2026 – 5:00 pm
